Search Medical Condition
Please enter condition
Please choose location from dropdown

Stent Clinical Trials

A listing of Stent medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (224) clinical trials

The Wingspan® Stent System with Gateway® Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter was approved in the United States (US) under a Humanitarian Device Exemption (HDE) and received CE Mark in 2005. This study is being conducted to fulfill Food and Drug Administration (FDA) post market safety surveillance requirements

Phase N/A

Cardiovascular disease is the leading cause of morbidity and mortality in industrialized nations, and atherosclerosis has been linked as the chief underlying pathology. Stroke as a result of the atherosclerotic carotid artery disease (CAD) is a common cause of death and a major reason for long-term disability worldwide1. Currently, it ...

Phase N/A

Multi center, non-blinded, non-randomized post approval study looking at the long-term performance of the Relay Thoracic Stent Graft System with Plus Delivery System by assessing the rate of aneurysm-related mortality at 5 years post-implant.

Phase N/A

Humanitarian Use for emergent, life-threatening free perforations, aka free contrast extravasations, into the pericardium in native coronary vessels or saphenous vein bypass grafts ≥ 2.75 mm in diameter.

Phase N/A

People with a wide-necked brain aneurysm are asked to participate in a research study being conducted by North Shore-Long Island Jewish Health System.

Phase N/A

Humanitarian Use Device - Intracranial artery stenosis - The WingspanTM Stent System and GatewayTM PTA Balloon Catheter have been developed for the treatment of intracranial artery stenosis. Patient Inclusion Criteria: Adults > 40 years old with symptomatic stenosis of one of those intracranial arteries: Internal carotid artery (ICA ), M1 ...

Phase N/A

A clinical study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System which was previously approved by the FDA. Patient Inclusion Criteria: >years of age Patients that need a stent in the coronary arteries Patient Exclusion Criteria: Cannot receive the protocol required dual antiplatelet therapy Currently taking warfarin or similar anticoagulant ...

Phase

The objective of this clinical investigation is to demonstrate the superiority of an Optical Coherence Tomography (OCT)-guided stent implantation strategy compared to an angiography-guided stent implantation strategy in achieving larger post-PCI lumen dimensions and improving clinical cardiovascular outcomes in patients with high-risk clinical characteristics and/or with high-risk angiographic lesions.

Phase N/A

The primary purpose of this study is to determine whether treatment with the Cobra PzF stent with 14 day Dual Anti-Platelet Therapy (DAPT) has a better safety profile compared to standard FDA approved Drug Eluting Stent plus 6-Month Dual Anti-Platelet Therapy in patients undergoing coronary intervention who also require oral ...

Phase N/A

The objective of this study is to evaluate the effectiveness of MicroVention Carotid Stent System used in conjunction with the Nanoparasol embolic protection system for the treatment of carotid artery stenosis in patients with elevated risk for adverse events following carotid endarterectomy.  The stent is a self-expanding implant with a ...

Phase N/A